Clari Vest Asset Management LLC Bio Techne Corp Transaction History

Clari Vest Asset Management LLC

$1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$71.62 - $86.62 $1.07 Million - $1.3 Million	-14,988 Reduced 47.91%	16,296 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $1.89 Million - $8.25 Million	23,430 Added 298.32%	31,284 $2.59 Million
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $688,267 - $954,546	-2,436 Reduced 23.67%	7,854 $2.23 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $871,209 - $1.21 Million	-2,700 Reduced 20.79%	10,290 $3.57 Million
Q1 2022 May 04, 2022	SELL	$353.85 - $487.79 $70,770 - $97,558	-200 Reduced 1.52%	12,990 $5.63 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $592,995 - $682,577	-1,300 Reduced 8.97%	13,190 $6.82 Million
Q3 2021 Nov 08, 2021	SELL	$444.87 - $538.88 $715,795 - $867,057	-1,609 Reduced 9.99%	14,490 $7.02 Million
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $160,141 - $209,199	509 Added 3.26%	16,099 $6.15 Million
Q3 2020 Nov 09, 2020	SELL	$232.22 - $282.96 $118,432 - $144,309	-510 Reduced 3.17%	15,590 $3.86 Million
Q2 2020 Aug 12, 2020	BUY	$185.43 - $279.56 $222,516 - $335,472	1,200 Added 8.05%	16,100 $4.25 Million
Q1 2020 May 04, 2020	BUY	$161.17 - $221.51 $161,170 - $221,510	1,000 Added 7.19%	14,900 $2.83 Million
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $75,872 - $88,836	-400 Reduced 2.8%	13,900 $3.05 Million
Q3 2019 Nov 12, 2019	BUY	$183.56 - $216.72 $2.62 Million - $3.1 Million	14,300 New	14,300 $2.8 Million
Q2 2018 Aug 10, 2018	SELL	$144.9 - $165.58 $2.39 Million - $2.73 Million	-16,475 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$131.46 - $151.04 $2.17 Million - $2.49 Million	16,475 New	16,475 $2.49 Million

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account